These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17720990)

  • 1. Serum phosphorus and the risk of progression of chronic kidney disease.
    Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2007 Dec; 22(12):3679-80. PubMed ID: 17720990
    [No Abstract]   [Full Text] [Related]  

  • 2. Is it time to modify the target range for serum phosphorus levels in chronic kidney disease (CKD).
    Savica V; Bellinghieri G; Santoro D
    J Ren Nutr; 2010 Mar; 20(2):65. PubMed ID: 20185069
    [No Abstract]   [Full Text] [Related]  

  • 3. Taking aim at targets.
    Palmer SC; Craig JC; Strippoli GF
    Nephrol Dial Transplant; 2009 May; 24(5):1358-61. PubMed ID: 19211650
    [No Abstract]   [Full Text] [Related]  

  • 4. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
    Sturm G; Kollerits B; Neyer U; Ritz E; Kronenberg F;
    Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is chronic kidney disease (CKD) a problem of great epidemiological relevance?].
    Lozano L; Sánchez R; Navarro J; Alcázar R
    Nefrologia; 2008; 28 Suppl 5():99-103. PubMed ID: 18847428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we improve the quality of life for dialysis patients?
    Kliger AS; Finkelstein FO
    Am J Kidney Dis; 2009 Dec; 54(6):993-5. PubMed ID: 19932876
    [No Abstract]   [Full Text] [Related]  

  • 7. Progression of chronic kidney disease in children with vesicoureteral reflux: the North American Pediatric Renal Trials Collaborative Studies Database.
    Novak TE; Mathews R; Martz K; Neu A
    J Urol; 2009 Oct; 182(4 Suppl):1678-81. PubMed ID: 19692051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitous nature and elusive role of phosphorus and vascular calcification.
    Goldstein-Fuchs J; Fouque D
    Am J Kidney Dis; 2009 Mar; 53(3):363-5. PubMed ID: 19231735
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
    Inaguma D; Tatematsu M
    Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A; Djurdjev O; Beaulieu M; Er L
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progression factors for chronic kidney disease. Secondary prevention].
    García de Vinuesa S
    Nefrologia; 2008; 28 Suppl 3():17-21. PubMed ID: 19018733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time for reflection predicts the progression of renal dysfunction in patients with nondiabetic chronic kidney disease.
    Takenaka T; Mimura T; Kikuta T; Kato N; Inoue T; Kanno Y; Ohno Y; Kobayashi T; Miyawaki Y; Suzuki H
    Clin Exp Hypertens; 2009 May; 31(3):220-30. PubMed ID: 19387898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of phosphate in chronic kidney disease--Phosphorus control by hemodialysis with long treatment time].
    Tanaka M
    Clin Calcium; 2009 Feb; 19(2):194-7. PubMed ID: 19182358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to K/DOQI practice guidelines for bone metabolism and disease.
    Hoy T; Fisher M; Barber B; Borker R; Stolshek B; Goodman W
    Am J Manag Care; 2007 Nov; 13(11):620-5. PubMed ID: 17988187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic kidney disease and the heart. Linked pathologies].
    Bardají A; Martínez-Vea A
    Rev Esp Cardiol; 2008 Jun; 61 Suppl 2():41-51. PubMed ID: 18590636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Vassalotti JA; Uribarri J; Chen SC; Li S; Wang C; Collins AJ; Calvo MS; Whaley-Connell AT; McCullough PA; Norris KC;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S56-68. PubMed ID: 18359409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review.
    Sigrist MK; Chiarelli G; Lim L; Levin A
    J Ren Care; 2009 Mar; 35 Suppl 1():71-8. PubMed ID: 19222735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.
    Sigrist MK; Taal MW; Bungay P; McIntyre CW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1241-8. PubMed ID: 17928470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood serum inorganic phosphorus: diagnostic significance and method of determination (review of the literature)].
    Titov VN; Tvorogova MG
    Lab Delo; 1991; (12):10-6. PubMed ID: 1724478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.